- Home
- ASGN vs VIR Comparison
ASGN vs VIR Comparison
Compare ASGN & VIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ASGN | VIR |
|---|---|---|
| Founded | 1985 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Professional Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.5B |
| IPO Year | 1996 | 2019 |
Fundamental Metrics
Financial Performance| Metric | ASGN | VIR |
|---|---|---|
| Price | $35.41 | $9.23 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 5 | 8 |
| Target Price | ★ $51.20 | $19.63 |
| AVG Volume (30 Days) | 549.3K | ★ 4.4M |
| Earning Date | 04-22-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 17.49 |
| EPS | ★ 2.60 | N/A |
| Revenue | ★ $3,980,400,000.00 | $68,556,000.00 |
| Revenue This Year | $3.26 | N/A |
| Revenue Next Year | $4.94 | $1,049.62 |
| P/E Ratio | $13.74 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $35.51 | $4.16 |
| 52 Week High | $65.51 | $10.91 |
Technical Indicators
Market Signals| Indicator | ASGN | VIR |
|---|---|---|
| Relative Strength Index (RSI) | 29.53 | 54.53 |
| Support Level | N/A | $8.67 |
| Resistance Level | $49.41 | $10.29 |
| Average True Range (ATR) | 1.64 | 0.56 |
| MACD | -0.33 | -0.10 |
| Stochastic Oscillator | 1.36 | 34.88 |
Price Performance
Historical ComparisonAbout ASGN ASGN Incorporated
ASGN Inc is a provider of information technology (IT) services and professional solutions, including technology, creative, and digital, across the commercial and government sectors. It operates through two segments, Commercial and Federal Government. The Commercial Segment, which generates the majority of the revenue, provides consulting, creative digital marketing, and permanent placement services to Fortune 1000 clients and mid-market companies. The Federal Government Segment provides mission-critical solutions to the Department of Defense, intelligence agencies, and civilian agencies.
About VIR Vir Biotechnology Inc.
Vir Biotechnology Inc is a clinical-stage biopharmaceutical company focused on powering the immune system by discovering and developing medicines for serious infectious diseases and cancer. The company uses its capabilities in antibody discovery and engineering, coupled with its proprietary AI engine dAIsY system, and the PRO-XTEN masking platform, to quickly and effectively discover and optimize potential new medicines. Its clinical development pipeline consists of investigational therapies like Tobevibart + elebsiran targeting the hepatitis delta virus (HDV), preclinical antibody candidates targeting HIV, and VIR-5500, VIR-5818, VIR-5525, and 7 PRO-XTEN programs targeting multiple solid tumors. Currently, the company generates revenue mainly by issuing license rights and through grants.